Skip to content
Search

Latest Stories

Mallya extradition trial hearing inconclusive

Embattled liquor baron Vijay Mallya, wanted in India on charges of fraud and money laundering allegedly amounting to around £1 billion, on Thursday (11) appeared in court in London for his extradition trial but the hearing was inconclusive as the defence is yet to complete its arguments.

The 62-year-old was back in the dock at Westminster Magistrates' Court as his defence team sought to argue against the admissibility of much of the evidence presented by the Indian government.


The hearing was expected to be one of the final hearings in the case but it remained inconclusive as the defence is yet to complete its arguments, which seek to demolish the Indian government's case.

The Crown Prosecution Service (CPS), arguing on behalf of the Indian government, is then set to respond and argue in favour of the evidence and against the defence's claim of "absence of a strong prima facie case on grounds of iniquity".

Due to prior diary commitments, no date has been set for the next hearing on the matter and Mallya has been bailed until April 2. Both sides will determine a date to return to court to complete their representations on the admissibility of evidence in the case within the next three weeks.

During today's hearing, Mallya's barrister, Clare Montgomery, argued that evidence that was claimed as a "blueprint of dishonesty" by the CPS was in fact a privileged conversation between Mallya and his lawyer about "legal advice in clear contemplation of litigation" and hence should be inadmissible.

On a separate category of evidence presented by the Indian government, Montgomery questioned the reliability of investigating officers in the case.

She pointed to over 150 pages of "near identical material" purporting to be statement of witnesses taken under Section 161 of the Indian CrPC.

Dismissing the nature and source of these witness statements, Mallya's legal team claimed they do not meet "obligations" under the India-UK extradition treaty to provide "proper" statements.

"They do not appear to be in any way an account of things that witnesses would have said but rather seem to be somebody else's analysis put into the mouths of the witnesses, down to the spelling mistakes," Montgomery said, adding that the documents were "identically reproduced" with not only the same words but also the same typing errors.

Chief Magistrate Emma Arbuthnot will rule on the evidence, following which she is expected to set a timetable for closing arguments and her verdict on whether the UK-based businessman can be extradited to India to face the fraud and money laundering allegations involving his now-defunct Kingfisher Airlines.

Judge Arbuthnot had also sought further clarifications related to availability of natural light and medical assistance at Barrack 12 of Mumbai Central Prison on Arthur Road, where Mallya is to be held if he is extradited from Britain.

The extradition trial, which opened at the London court on December 4, is aimed at laying out a prima facie case of fraud against the tycoon, who has been based in the UK since he fled India in March, 2016.

It will also seek to prove that there are no "bars to extradition" and that Mallya is assured a fair trial in India over his erstwhile airline's alleged default of over £1 billion in loans from a consortium of Indian banks.

Mallya was arrested by Scotland Yard on an extradition warrant in April, 2017 and has been out on bail on a bond worth £650,000.

If the judge rules in favour of the Indian government, the UK home secretary will have two months to sign Mallya's extradition order.

However, both sides will have the chance to appeal in higher courts in the UK against the chief magistrate's verdict.

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)
Getty Images

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less